Trastuzumab biosimilar (Hanwha Biologics)
曲妥珠单抗生物类似药 (Hanwha Biologics)
Report date: 2025/02/13 20:00:05
Base Information
Drug NameTrastuzumab biosimilar (Hanwha Biologics)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2024/09/19
Country/Territory +[15]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanwha Biologics
China Registration ClassN/A
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A